Cargando…
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
Chloroquine (CQ) and its derivative, hydroxychloroquine (HCQ), have attracted wide attention for treating coronavirus disease 2019 (COVID-19). However, conflicting outcomes have been found in COVID-19 clinical trials after treatment with CQ or HCQ. To date, it remains uncertain whether CQ and HCQ ar...
Autores principales: | Ho, Tzu-Chuan, Wang, Yung-Hsuan, Chen, Yi-Ling, Tsai, Wan-Chi, Lee, Che-Hsin, Chuang, Kuo-Pin, Chen, Yi-Ming Arthur, Yuan, Cheng-Hui, Ho, Sheng-Yow, Yang, Ming-Hui, Tyan, Yu-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922580/ https://www.ncbi.nlm.nih.gov/pubmed/33671315 http://dx.doi.org/10.3390/pathogens10020217 |
Ejemplares similares
-
Pulmonary Findings of [(18)F]FDG PET/CT Images on Asymptomatic COVID-19 Patients
por: Ho, Tzu-Chuan, et al.
Publicado: (2021) -
The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
por: Ho, Tzu-Chuan, et al.
Publicado: (2021) -
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021) -
Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging
por: Yang, Ming-Hui, et al.
Publicado: (2021) -
Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)